| 12145901 |
Process for preparing tetralin compounds |
Joel Worley Beatty, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Balint Gal, Karl T. Haelsig +9 more |
2024-11-19 |
| 12103907 |
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha |
Joel Worley Beatty, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Balint Gal, Tezcan Guney +19 more |
2024-10-01 |
| 12071411 |
Inhibitors of HIF-2α and methods of use thereof |
Joel Worley Beatty, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Balint Gal, Clayton Hardman +9 more |
2024-08-27 |
| 11787762 |
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha |
Joel Worley Beatty, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Balint Gal, Tezcan Guney +19 more |
2023-10-17 |
| 11738008 |
N-methyl-D-aspartic acid receptor modulators |
Dennis C. Liotta, Stephen F. Traynelis, David Menaldino |
2023-08-29 |
| 11407712 |
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α |
Joel Worley Beatty, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Balint Gal, Tezcan Guney +19 more |
2022-08-09 |
| 10647679 |
N-methyl-D-aspartate receptor (NMDAR) potentiators, pharmaceutical compositions, and uses related thereto |
Katie L. Strong, David Menaldino, Dennis C. Liotta, Stephen F. Traynelis, Rose M. Freel |
2020-05-12 |